Stage IIIA Hepatocellular Carcinoma AJCC v7 Recruiting Phase 1 Trials for Guadecitabine (DB11918)

IndicationStatusPhase
DBCOND0090228 (Stage IIIA Hepatocellular Carcinoma AJCC v7)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03257761Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerTreatment